ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OSCR vs MOH // EV/EBITDA & P/E VALUATION

Oscar Health Inc. (NYSE) VS. Molina Healthcare Inc (NYSE) • 15-METRIC TALLY: OSCR 4 — MOH 7
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OSCR VS. MOH) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OSCR MOH SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — 13.10% — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% 17.20% -52.20 MOH /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 11.4x — TIE /valuation <GO>
Free Cash Flow Yield 11.51% -6.12% +17.63 OSCR /fcf-yield <GO>
Operating Margin -60.00% 1.70% -61.70 MOH /operating-margins <GO>
Net Profit Margin -60.00% 1.00% -61.00 MOH /net-margins <GO>
Revenue Growth (YoY) 39.00% 11.70% +27.30 OSCR /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.45 4.34 -3.89 MOH /balance-sheet <GO>
Piotroski F-Score Quality 6/9 4/9 +2.00 OSCR /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 44.2 46.2 -2.00 MOH /rsi-technicals <GO>
10Y Yield & FRED Macro Beta 0.97 0.94 +0.03 OSCR /macro-sensitivity <GO>
Forward P/E Multiple 23.0x 20.5x +2.50 MOH /forward-pe <GO>
Enterprise Scale & Market Cap $9.50B $10.39B -$882.0M MOH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OSCR REV MOH REV OSCR GROSS % MOH GROSS % OSCR FCF MOH FCF
FY 2025 $28.6M $45.43B — 13.1% $1.09B -$636.0M
FY 2024 $20.6M $40.65B — 15.3% $977.3M $544.0M
FY 2023 $21.4M $34.07B — — -$273.1M $128.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OSCR // BETA 0.97
MOH // BETA 0.94